Fig. 4.
Kaplan-Meier curves comparing overall survival (OS) in (a) IDH mutated and 1p/19q codeleted low-grade glioma (LGG) versus (b) IDH mutated without 1p/19q codeletion LGG versus (c) IDH mutated and 19q lost LGG versus (d) IDH wild-type LGG The comparison was conducted in the training cohort (Panel a) and in the validation cohort (Panel b). Abbreviations: mut, mutation; ns, non-significant ; WT, wild-type.